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ABSTRACT 
Background: Environmental particle exposure is known to have negative health 
effects. There is limited knowledge about how size and origin of particles 
influence these effects. There is also little known regarding the fate of ultrafine 
particles (particles in nanosize;< 100 nanometers in diameter) after being inhaled.  
Aim: The main objective of this thesis was to study acute health effects in humans 
and their potential underlying mechanisms, resulting from exposure to particles of 
different origins. Another aim was to develop a method for measuring human lung 
retention (clearance) of ultrafine carbon particles. 
Methods: In this human exposure study, twenty healthy volunteers and sixteen 
individuals with sensitive airways diagnosed with mild asthma were exposed to a 
subway environment and a control environment for two hours each. Acute health 
effects in the airways and blood were measured using different markers indicating 
inflammation, effects on coagulation and lung function. 
 
A new exposure method was developed for the study of lung retention of inhaled 
ultrafine particles Carbon particles were labeled with radioactive indium-111. The 
labeling allowed one week of follow up of particulate retention in ten healthy 
volunteers. One volunteer was followed for totally 29 days. 
Results: After exposure to a subway environment, healthy individuals had 
significant increase in fibrinogen (coagulation factor) and regulatory T-cells 
expressing CD4/CD25/FOXP3 in peripheral blood. In asthmatics we found a 
statistically significant increased frequency of CD4 cells expressing T-cell 
activation marker CD25 in bronchoalveolar (lung) lavage fluid but no significant 
increase of regulatory T-cells in blood. 
We developed a method for labeling and generating ultrafine carbon particles 
with a radioactive isotope indium-111 for use in human studies. A follow-up of 
healthy volunteers who inhaled the particle aerosol found a limited deposition of 
particles in the central airways. Seven days after exposure, measured lung 
retention was 91% at the group level. After correction for free radioactivity 
leaching from urine and blood samples, respectively mucociliary clearance from 
the central airways, the cumulative lung-particle retention was approximated to 
96%. There was little translocation of particles from the lungs to the blood 
circulation (0.3%). The volunteer who was followed up for a total of 29 days 
demonstrated 10% further clearance of particles from the lungs. 
Conclusion: Healthy individuals and asthma patients display different 
inflammatory responses following exposure to a subway environment. The health 
effects were not as pronounced in comparison to our previous studies performed 
in a road-tunnel environment with similar mass levels of particles with diameters 
<2.5 µm and <10 µm (PM2.5 and PM10), but with a higher number concentration of 
ultrafine particles, nitrogen monoxide and dioxide than in the subway. The 
different results show that health-risk assessment cannot be based solely on mass 
concentration information such as PM2.5 and PM10. More complex measurements 
  
of particles are needed, and should include the number concentration levels of 
ultrafine particles as well as knowledge about the source of the particles.  
Results from deposition and retention studies indicate limited translocation to 
circulating blood in healthy lungs during the first week, with faster clearance from 
central lung regions compared to the peripheral regions. This is probably due to 
mucociliary clearance from the larger airways.  
 
 
  
SAMMANFATTNING 
Akuta hälsoeffekter och möjliga mekanismer av inhalerade partiklar med olika 
ursprung, samt retention i lungan  
Bakgrund: Det är känt att exponering för partiklar via omgivningsluften ger 
upphov till negativa hälsoeffekter. Det är emellertid mer oklart i vilken grad 
partiklarnas storlek och ursprung påverkar effekterna på hälsan. Ett annat 
tämligen okänt område är i vilken omfattning ultrafina partiklar (nanopartiklar, 
<100 nm i diameter) tas upp i kroppen efter inandning. 
Syfte: Syftet med studien var att kartlägga och förklara akuta hälsoeffekter hos 
människa till följd av exponering för olika sorters partiklar. Dessutom avsågs att 
utveckla en metod för bestämning av retention (clearance) av ultrafina 
kolpartiklar (grafit) i lungan.  
Metod: Tjugo friska försökspersoner samt sexton individer med känsliga 
luftvägar, diagnostiserade som personer med lindrig astma, deltog i studien. 
Personerna exponerades för omgivningsluften i tunnelbanan respektive en 
kontrollmiljö i två timmar vardera. Akuta hälsoeffekter studerades genom att 
mäta lungfunktion och genom analys av olika inflammatoriska markörer i blod 
och bronksköljvätska. Dessutom studerades effekt på koagulation i blod. 
En ny metod för exponering utvecklades för att användas i studien av retention av 
inhalerade ultrafina partiklar. Kolpartiklar inmärkta med radioaktivt indium-111 
möjliggjorde uppföljning av huruvida aerosolpartiklar stannade kvar i lungan hos 
tio friska individer i sju dagar. Utvecklingen hos en av försökspersonerna följdes i 
totalt 29 dagar. 
Resultat: Efter exponering för miljön i tunnelbanan uppvisade friska individer en 
signifikant ökning av fibrinogen (koagulationsfaktor) och regulatoriska T-celler 
(CD4/CD25/FOXP3) i blod. Hos astmatikerna påvisades en signifikant förhöjd 
frekvens av CD4 celler som uttrycker  
T-cellsmarkören CD25 in bronksköljvätskan, men däremot ingen signifikant 
ökning av regulatoriska T-celler i blodet. 
En metod utvecklades även för att skapa ultrafina kolpartiklar, inmärkta med den 
radioaktiva isotopen indium-111, som lämpar sig för att användas i studier med 
försökspersoner. En uppföljande studie med friska frivilliga som andades in 
aerosolen endast kunde påvisa en begränsad deponering av partiklar i de centrala 
luftvägarna. Sju dagar efter exponering mättes motsvarande 91% av 
radioaktiviteten i lungorna. Efter korrigering för icke-partikelbunden 
radioaktivitet i blod- och urinprover, samt för mukociliär transport från de större 
luftvägarna, uppgick den kumulativa partikelretentionen till 94%. En obetydlig 
överföring (translokering) av partiklar till blodomloppet förekom (0,3%). Den 
försöksperson som studerades under totalt 29 dagar uppvisade ytterligare 10% 
minskning av mängden partiklar i lungorna mellan dag 7 och 29. 
  
Slutsatser: Friska individer och personer med diagnostiserad astma uppvisar 
olika inflammatorisk respons efter att ha utsatts för tunnelbanemiljön. Resultaten 
skiljde sig även åt från tidigare studier genomförda i en vägtunnel med jämförbar 
massa av partiklar med diameter <2.5 µm och <10 µm (PM2.5 och PM10), men med 
en större andel ultrafina partiklar samt högre koncentration kvävemonoxid och 
kvävedioxid. De olika resultaten visar att hälsoriskbedömningar inte enbart kan 
grunda sig på information om total partikelmassa såsom angivelser för PM2.5 och 
PM10. Det är nödvändigt att utföra mer förfinade mätningar av partikelförekomst, 
vilket skall inkludera antalet ultrafina partiklar per volymsenhet liksom även 
kännedom om partiklarnas ursprung. 
Resultaten från studierna av deposition och retention pekar mot att 
translokeringen av partiklar från lunga till blod är begränsad under första veckan 
efter exponering. Borttransporten var snabbare från de centrala regionerna av 
lungan jämfört med perifera delar, troligen beroende på mukociliär transport från 
de större luftvägarna.   
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1 GENERAL INTRODUCTION 
1.1 OUTDOOR AIR POLLUTION - PARTICLES  
High particle levels in the subway environment 
Air pollution has negative health effects. Combustion exhaust from motor traffic is 
a major contributor to ambient air pollution. One way of limiting overall air 
pollution exposure related to motor exhaust is to expand the subway 
underground system. However, in Stockholm, the levels of aerosol mass 
concentration levels of particulate matter Pin the subway are 5–10 times higher1 
than at street level in the inner city [1] and are comparable to particulate mass 
concentrations measured in a road tunnel in the same city [2]. Particulate mass 
concentration levels in the subway change little from day to day. The 
concentrations of airborne of particles in the subway system in Stockholm are 
within levels reported elsewhere worldwide like in Amsterdam [3], Helsinki [4], 
London [5], New York [6], Rome [7] and Seoul [8].  
Specific size and composition of subway particles 
In the subway particles are rather large, more than 1 micrometer in diameter, and 
mainly originate from tracks and wheels, with a high content of iron. Compared to 
the concentration in the street level environment, the number concentration of 
ultrafine particles, with diameter less than 100 nanometers, however, has a much 
lower magnitude in the Stockholm subway environment. 
Ambient particles vary not only in size, but also by source and chemical 
composition. They may consist of metals, as in the subway environment, or 
include other chemicals compounds such polycyclic aromatic hydrocarbons (PAH) 
[9, 10], elemental carbon  [11, 12], naturally occurring dust, pollen, sea salt, 
endotoxins [13] or other motor combustion related compounds.  
Assessment of ambient particle exposure  
Particulate air pollution is usually monitored by gravimetric measurements of 
PM1, PM2.5 and PM10, where PM stands for particulate matter and the subscripts 
for diameters of <1 µm, <2.5 µm and <10 µm, respectively. Motor exhaust is a 
major source of airborne nano-sized particles, also called ultrafine particles. These 
are rarely monitored. Because of their low mass, measurement of number 
concentration is more relevant in this case. 
Air quality – existing legislation 
Health effects are seen at very low levels after exposure, which make it hard to set 
threshold levels. The WHO guidelines for PM10 establish 50µg/m3 averaged over 
24 hours and 20µg/m3 as an annual average for air quality [11]. Within the EU, 
Directive 2008/50/EC sets ambient air quality norms for Member States. The 
exposure limit to fine particulates (PM2.5) is set at 20µm/m3 (based on a 3-year 
average) and becomes legally binding in 2015. For PM10 the exposure limits are 
set at 50µg/m3 as a 24-h average (not to be exceeded more than 35 times per 
year) and 40µg/m3 as an annual average [14]. Stockholm currently does not fulfill 
the EU norm for PM10 in urban air. 
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Other air pollutants 
Outdoor ambient air pollution contains not only particulate matter but also 
gaseous compounds such as nitrogen oxides (NO and NO2), sulfur dioxide (SO2), 
ozone (O3). All are associated with negative health effects. 
 
1.2 HISTORIC PERSPECTIVE, EPIDEMIOLOGY AND HEALTH EFFECTS 
OF PARTICLES 
The awareness of air pollution and its health effects was pointed out already in 
1661, when John Evelyn published a report on air pollution and its negative 
effects on health. Almost 300 years later, on 6 December 1952, extremely heavy 
smog in London led to increased mortality and hospitalization. ).  Earlier, in 
1930´s, a similar event occurred in Meuse valley, in Belgium [15]. Despite this, 
British epidemiologists concluded in 1979 that there was no negative health effect 
from particulate air pollution [16]. However, in 2006 the U.S. Environmental 
Protection Agency (EPA) reported that “Inhalation of fine particles is causally 
associated with premature death at concentrations near those experienced by 
most Americans on daily basis” [17].  
Epidemiological studies 
Epidemiological studies agree nowadays that particulate matter air pollution is 
associated with health effects. The associations have been found in both short-
term studies, based on daily variation in air pollution and health parameters, and 
in long-term studies where individuals have been followed over a longer period of 
time. An advantage in short-term studies is that the population may serve as it´s 
own control. One limitation is to make assumptions that the exposure is 
representative for larger population [18].  
Two frequently cited studies are the APEAH (Air pollution and Health: a European 
Approach), which included 10 European cities [19], and NMMAPS (the National 
Morbidity and Mortality Air Pollution Study), covering cities in the US [20, 21]. 
Through coordination between different cities, meta-analyses were performed 
strengthening earlier studies. In the U.S. there was a strong association between 
PM2.5 and general risk of death and caused by cardiovascular and respiratory 
illnesses. In western European cities the risks of daily deaths from cardiovascular 
and respiratory diseases increased with elevated concentration of black smoke 
and in sulfur dioxide levels. No relations with daily mortality and nitrogen dioxide 
were shown. 
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Acute health effects - inflammation, respiratory and cardiovascular illnesses 
Acute health effects may be measured with different markers indicating signs of 
increased inflammation, increased coagulation and decreased lung function. 
Specifically, particulate matter (PM) air pollution has been identified in several 
epidemiological studies as associated with adverse health effects, both short and 
long term, including mortality [20, 22, 23], lung cancer [24], cardiovascular 
disease [24-27] respiratory illnesses [25, 27]. On the other hand, subway 
employees and other professional drivers do not show any increased relative risk 
for myocardial infarction [28]. 
Particular matter has been associated with mortality and hospital admission due 
to respiratory and cardiovascular diseases, but the mechanisms behind these 
effects are still not fully understood. One theory is that airborne particulate matter 
increase inflammatory factors that increase coagulation. Particulates could also 
have a direct impact on the heart causing changes in heart-rate variability. [29] 
High airborne mass concentration may lead to “lung overload” with failed 
clearance leading to inflammation [30].  
Earlier in vivo studies from our group have shown that particulate air pollution 
from city traffic induce inflammatory reactions in the lower airways. Larsson et al 
showed increased amount on inflammatory cells in the bronchial alveolar lavage 
(BAL) fluid in a study on 16 healthy individuals. [2] 
Susceptible population – asthmatics 
Individuals with asthma have a chronic inflammation in their airways and are 
more vulnerable to air pollutants than a healthy population, and inhaled 
particulate air pollution may exacerbate pre-existing lung inflammation [31]. 
Asthma symptoms and increased need for medication are most strongly 
associated with ultrafine particles and with PM2.5 rather than PM10 [32-35]. 
Approximately 10% of Swedish adults are diagnosed with asthma. Asthma is 
defined as a chronic inflammation in the airways with variable lung function, also 
called “airway obstruction.” The symptoms of asthma: episodes of wheezing, 
cough, chest tightness and breathlessness, are caused by swelling and increased 
mucus production in the airways. Many inflammatory cells are involved in asthma 
pathogenesis, particularly mast cells and eosinophils. Also T cells are also likely to 
play an important role involving various cytokines. For details, see “Immune 
defence” below. 
Asthma is more common in children than in adults. Atopic (allergic) diseases such 
as atopic eczema and allergic rhinitis are considered to be risk factors for 
development of asthma. Approximately 80% of asthmatic children and 40–50% of 
asthmatic adults have atopic asthma [36]. Other risk factors are genetic 
predisposition, smoking parents as well as indoor and outdoor environmental 
factors (air pollution).  
Asthma is less common in Eastern Europe, rural Africa, India and China. In the 
Westernized countries asthma has increased since the early 1960s. Genetic 
predisposition alone cannot explain the increase. The increase may be due to 
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increased asthma awareness. However, focus has been put on changes in 
environmental factors such as air pollution. 
Previous exposure studies with asthmatics 
A corresponding in vivo exposure study performed in a road tunnel in Stockholm, 
including 14 asthmatics exposed for two hours, showed increased levels of 
inflammatory mediators, such as the pro-inflammatory IL-12 and TNF-α as wells 
the anti-inflammatory IL-10, in a nasal lavage for a subgroup of seven asthmatics 
without ongoing medical corticosteroid treatment [37]. The same road tunnel was 
used in another exposure study with 20 asthmatic volunteers that were exposed 
for only 30 minutes. In comparison to a control (clean) environment, the road 
tunnel enhanced asthmatic reaction (reduction of lung function) to inhaled 
allergens.[38] 
Short-term exposure (1 hour) to diesel exhaust (with high PM10 levels) has also 
been shown to increase bronchial hyper responsiveness in asthmatic subjects, 
which is an important feature of asthma. The increase was detected one day post 
exposure. There was also an induction of the pro-inflammatory IL-6 in mucus that 
is coughed up from the lower airways (sputum). [39] In London, 60 adults with 
asthma were exposed (2 hours) for a busy street environment, as well as for a 
park environment for equally long time. The exposure for city air pollution 
reduced the lung function (FEV1 and FVC). The reduction was most associated 
with ultrafine particles and elemental carbon.[40] 
Children and elderly 
Other susceptible groups are children and the elderly. The first pediatric studies 
(late 1980s) were based on airborne emissions from a steel mill in Utah Valley. 
Associations were seen between low levels of PM10 and fewer hospital admissions 
in children. [41] A four-year follow-up cohort of 1 678 children from Southern 
California revealed negative effects of air pollution (NO2, PM2.5 and elemental 
carbon) on lung function development [42]. Also, a four-year prospective birth 
cohort of 4 089 Swedish children has found a relation between traffic indicators 
(NOx and PM10) and development of airway disease and sensitization for allergens 
in children [43]. 
The elderly are also considered to be a susceptible population to air pollution. A 
study by Cakmak S et al estimated a mortality rate associated with ambient air 
pollution and observed an association between PM10 and the mortality of 
population over 85 years (three times higher) in comparison to those under 65 
years. Mortality related to PM10 was three times higher for the elderly group. [44] 
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1.3 IMMUNE DEFENCE – RESPONSE TO PARTICULATE AIR 
POLLUTION 
Airborne particulates from air pollution may induce inflammatory responses. 
Induction of inflammation or anti-inflammatory agents may vary from minutes to 
days.  
White blood cells 
Blood consists of 55% plasma and 45% blood cells. Cells circulating in blood are: 
blood platelets (thrombocytes), red blood cells (erythrocytes) and white blood 
cells (leukocytes), where the latter are involved in the immune defence. Only a 
small percent of the leukocytes are found in blood. They are mainly located in 
other tissues, such as lung tissues. An increased number of leukocytes may 
indicate an ongoing inflammatory process or a down-regulated immune defence. 
Leukocytes are usually divided into granulocytes (neutrophils, eosinophils, 
basophils), lymphocytes (B-, T-, NK-cells) as well as monocytes (macrophages and 
dendritic cells).  Figure 1 summarizes the white blood cells and their role in the 
defence systems. 
Innate and adaptive immune system 
The immune system is a network of organs, tissues, cells and inflammatory 
mediators that protects the body from pathogens. It is usually divided into the 
nonspecific (innate) and specific (adaptive) immune system, with secreted 
mediators that overbridge the two systems. The first line of defence is performed 
by the nonspecific immune system. The leukocytes involved there specialize in 
digesting (phagocytosis) foreign material.  The cells in the innate defence system 
that have phagocytic ability are neutrophils, monocytes, macrophages and 
dendritic cells.  
The adaptive immune response has two main cell types: B and T cells. They are 
able to distinguish individual pathogens (infectious agents) or other agents by 
using cell-surface receptors. An useful protocol for identifying whether molecules 
(receptors or cell adhesion) on the surface on white blood cells are present or not, 
is the cluster of differentiation (CD) nomenclature. There are several hundred CD 
markers, for example CD3 denotes T cells. T cells are further divided into 
regulatory T cells, cytotoxic T cells and T helper (Th) cells. The CD markers that 
are most frequently discussed in this thesis are found in the list below.  Sometimes 
symbols “+”(pos) or “-“(neg) are used in connection to CD markers. This is used to 
indicate whether a certain cell expresses or lacks the specific CD molecule. 
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Figure 1. A summary the white blood cells in the immune system, with their main 
functions. 
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A useful protocol for identifying whether molecules (receptors or cell adhesion) 
on the surface on white blood cells are present, or not, is the cluster of 
differentiation (CD) nomenclature. There are several hundred CD markers, for 
example CD3 denotes T cells. T cells are further divided into regulatory T cells, 
cytotoxic T cells and T helper (Th) cells. The CD markers that are most frequently 
discussed in this thesis are found in the list below.  Sometimes symbols “+”(pos) 
or “-“(neg) are used in connection to CD markers. This is used to indicate whether 
a certain cell expresses or lacks the specific CD molecule. 
 
General markers  
CD45 Defines white blood cells (leukocytes) 
CD69 Used to detect early activation (1-2 hours) of lymfocytes 
T-cell markers 
CD3  Defines T cells 
CD4 Defines T helper (Th) cells  
CD8 Is expressed on cytotoxic T cells 
CD25 Used to detect early activation of activated T cells. If the 
response is high it may indicate presence of regulatory T 
cells, on which CD25 is also expressed 
FOXP3 (fork head 
box protein 3) 
Transcription factor2 for regulatory T cell, preferentially 
CD4posCD25bright.  
B-cell marker 
CD19  Defines B-cells 
NK-cell marker 
CD56posCD16pos  Defines NK cells or NK T cells 
 
Inflammatory mediators 
There are numerous signaling protein molecules (cytokines and chemokines) that 
are secreted by cells to facilitate intercellular communication during inflammatory 
responses. In this thesis, both pro-inflammatory cytokines (IL-1, IL-6, IL-8, IL-12, 
TNF-α) and an anti-inflammatory cytokine  
(IL-10), are discussed.  
 
1.4 PREVIOUS EXPOSURE STUDIES IN SUBWAY ENVIRONMENT 
In vitro results 
An in vitro study showed that particulate air pollution in subway air was more 
genotoxic than in street-level air, as subway particles induced oxidative stress in 
cultured human lung cells [45]. In two other in vitro studies a cytokine release (IL-
6, IL-8 and TNF- ) could be stimulated from human macrophages by particles 
derived from a subway station air as well by particles from air along a heavily 
trafficked urban street. Street-level airborne particulate air pollution was the most 
potent stimulators. [46, 47] Similar results regarding cytokine release were shown 
in an in vitro animal study using a murine macrophage-like cell line). Induction of 
lipid peroxidation, arachidonic acid release and formation of ROS (reactive oxygen 
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  A transcription factor is a molecule/protein that binds to a specific DNA sequences. 
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species) were however, stronger for subway air particles than for urban street air 
particles. [48] 
In vivo results 
To our knowledge only one study has been performed investigating acute health 
effects in humans after exposure to a subway environment and none regarding 
asthmatics. Personal PM10 exposure has been assessed in personnel working in 
the Stockholm subway environment. Exposure levels for subway drivers were 
compared with platform workers. The latter group was exposed to four times 
higher levels of particulate matter than the train drivers. [49] This suggests that 
the subway environment exposure potentially impacts citizens using the subway. 
Another study showed that inflammatory response, as measured as blood plasma 
concentrations of plasminogen activator inhibitor-1 (PAI-1), interleukin-6 (IL-6) 
and fibrinogen, had a tendency to be higher for subway platform workers than for 
train drivers and subway ticket sellers. Measurements were performed on non-
smoking, healthy workers after two non-working days, and a second sample after 
two working days. [50] 
 
1.5 DEPOSITION AND RETENTION OF INHALED PARTICULATE AIR 
POLLUTION 
Particle surface area deserves serious consideration. Ultrafine particles have a 
greater surface area per mass unit compared to larger sized particles, and are 
thereby likely to be more reactive and to promptly initiate an inflammatory 
process [51-53] 
In vivo human lung retention data obtained under controlled exposure conditions 
play a fundamental role in understanding the biological pathways of particulate 
pollutants in the human body. How do ultrafine particles in air pollution behave in 
the body after being inhaled? Do they remain in the lungs or are they eliminated 
(cleared) from the body by mucociliary clearance or other mechanisms? Is there a 
translocation to the blood circulation and further distribution to other organs? 
Relevance of size and solubility of particles 
Particles deposited in the lungs may accumulate or be eliminated by different 
biological mechanisms such as mucociliary transport, phagocyte action (ingestion) 
and pinocytosis (cells absorbtion and engulfment). However, clearance efficiency 
depends on particulate distribution within the lung structure and the 
physicochemical characteristics of the inhaled particles. Particularly, mucociliary 
clearance from human airways has been suggested to be particle-size dependent 
[54] rather than composition dependent. Ultrafine particles are also believed to 
have more toxic properties than larger particulate matter due to their ability to 
reach into the alveoli, where gas exchange occurs, and be further translocated to 
secondary organs [55, 56] Ultrafine particles have relative large surface, which 
increase effect per mass  there are also results indicating that macrophages have a 
reliative inability to phagocytize nanosized particles quickly [57]. 
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Another on-going discussion regarding the ultrafine particles is whether they 
impaire phagocytic ability of macrophages once they reach the alveoli region. In 
vitro studies with human and rat alveolar macrophages exposed to ultrafine 
carbon particles showed that a reduced phagocytic capacity when exposed to 
silica particles [58]. In an extended study, apart from the ultrafine carbon 
particles, also particles derived from diesel exhaust had the same inhibitory effect 
on the phagocytic ability human alveolar macrophages when exposed to silica 
particles and microorganisms. The authors concluded that this effect may result in 
more exacerbations of subgroups of chronic inflammation in their airways, as it 
may increase susceptibility to infections. [59] 
Labeling of particles and follow up by gamma camera 
Scintigraphic registration techniques (gamma cameras) may be used for lung 
deposition, retention and clearance studies. It is based on particles labeled with a 
radioisotope, inhaled and then followed externally by gamma counting. Various 
isotopes may be used for the labeling. Technetium-99m (99mTc) has long been 
used for human studies [60, 61]. Nonetheless, there are still few human studies on 
translocation using ultrafine carbon particulates aerosol that correspond to the 
size of particles in motor exhaust.  
The risks of using ionizing radiation 
Radiation of a substance is due to the instability of the atom nucleus (balance 
between protons and neutrons). If the nucleus is unstable, then the substance will 
be “radioactive” and accompanied by emissions of radiation energy. Once the 
atom reaches a stable configuration, no more radiation is emitted, and the 
material will become non-radioactive. The half-life is the amount of time that it 
takes for a substance undergoing decay to decrease by half. 
Measurement of radioactivity depends on the objective, as shown below. 
Retention studies use activity measurements. 
Unit Abbreviation Representing Used to measure 
Becquerel Bq Disintegrations per second Radioactivity 
Sievert Sv Absorbed radiation dose Biological effect 
Some examples of radiation levels are as follows: A medical x-ray lung 
examination delivers a mean dose of 0.01 mSv, a round-trip flight over the Atlantic 
results in a dose of 0.1 mSv,  and a medical x-ray lung examination delivers a mean 
dose of  0.2 mSv (0.1-5 mSv), and a more extensive stomach x-ray  delivers up to a 
dose of 20 mSv. This can be compared to the mean yearly dose of 4–5 mSv that 
each person in Sweden is exposed to due to natural background radiation 
(including radon). [62] 
Radiation energy can liberate an electron from an atom and become an ion. There 
are various forms of ionizing radiation, such as beta (β) radiation consists of 
electrons, which can be stopped by an aluminum plate. For medical investigations 
α and β radiation should be avoided. 111In generates gamma (γ) radiation that 
consists of energetic photons. This radiation is detected by gamma camera. Also 
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technetium-99m (99mTc) generates γ-radiation, which can be stopped by 5-mm 
thick lead shield. 
 
1.6 EXPOSURE STUDIES WITH ULTRAFINE PARTICLES 
Labeling with Technetium-99m isotope 
Data from controlled exposure to ultrafine particles labeled with a radionuclide 
have provided basic information about the biological pathways of the ultrafine 
particles in the human body after inhalation. Insoluble carbonaceous ultrafine 
particles labeled with 99mTc have been frequently used in short-term human lung 
clearance measurements. Our previous human studies with ultrafine carbon have 
shown a slow clearance rate. Most particulates were retained in the lung region 
after two days. At 24 hours, no significant translocation of 100 nm carbon 
particles from the lungs to the blood was observed in either in healthy subjects or 
in a group of asthmatics or smokers [63]. Furthermore, Mills et al has shown that 
99mTc particles remain in the lungs for at least 6 hours after inhalation [64]. The 
result contradicts interpretations from another study made by Nemmar et al[65]. 
In their study five healthy volunteers inhaled 99mTc particulate aerosol. The 
particles rapidly passed into the systemic blood circulation with a peak within 10-
20 minutes. In the Nemmar et al study there may have been a large amount of 
non-bound radioisotope, as thyroid glands and bladder was visible in the whole 
body scan (normally non-bound 99mT is translocation to that part of the body).  
The above mentioned studies share a common problem with measurement error 
due to the poor sensitivity of gamma camera, as well as the physical properties of 
the radioisotopes that is used.  The short physical half-life of 99mTc (six hours) only 
permits short-term clearance studies of couple of days post administration.  
There is a possibility that particles enter the lung tissue without blood 
translocation [66], which may explain the different results. A longer follow-up 
(900 days) period of Teflon labeled a gold-195 radioisotopes (195Au) in ten 
healthy men, showed that there was a translocation within the thoracic region 
with accumulation of particles in lymph nodes [67]. 
Indium-111 – a suggested isotope for retention studies 
Both the time-dependent stability of the chemical bound between particle and 
radioisotope and the limited sensitivity of the radiation detectors hamper 
accuracy in long-term lung clearance studies in humans when using scintigraphic 
techniques. Indium-111 (111In) has been suggested as a candidate to replace 99mTc 
for labelling of carbonaceous particles in human exposures. Traditionally, 111In 
complexes (physical half-life 2.8 days) have been routinely used for in vivo 
diagnostic nuclear medicine procedures such as for localization of primary and 
metastatic neuroendocrine tumours bearing somatostatin receptors (indium-
pentetreotide), for evaluating patients with fever of undetermined origin (indium-
granulocyte), etc.  
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2 GENERAL SCOPE – HUMAN EXPOSURE STUDIES 
The title of this thesis is: “Potential mechanisms for acute health effects and lung 
retention of inhaled particles of different origin”.  
The thesis consists of human exposure studies with particles of different origin, 
sizes and chemical composition. The topic can be described schematically as 
below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Papers I and II focus on wear particles occurring in a subway environment. 
Exposure studies were performed in a subway environment (“Odenplan Station” 
in Stockholm, Sweden) with healthy volunteers respectively asthmatics. The set-
up was similar to previously performed exposure studies in a road tunnel 
(“Söderledstunnel“ in Stockholm). 
 
Paper III describes a method to label nanosized (ultrafine) particles with a 
radioactive isotope, indium-111, for use in human lung deposition and 
translocation studies. The method was used for the exposure study on healthy 
volunteers described in Paper IV. 
 
        Inhaled particles 
       -deposition 
       -different sizes 
       -different origin 
        and chemistry 
Retention Acute health 
effects 
-mechanisms 
-inflammation 
-lung function 
-coagulation 
-mechanisms 
-retention 
-clearance 
-translocation 
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3 AIMS AND SPECIFIC RESEARCH QUESTIONS  
The primary objective of this thesis was to study acute health effects and their 
potential underlying mechanisms resulting from exposure to inhaled particles 
with different size and composition. The knowledge gained may also provide 
valuable information regarding the process of setting limit values for airborne 
particles or particulate matter and personal protection.  
 
The specific research questions and aims were: 
1) Does exposure to a subway environment cause airway inflammatory 
response? 
 
2) Are there differences in acute health effects due to exposure to particles 
that originate from different sources or environments, such as from car 
traffic and a subway environment? 
 
3) Do asthmatics respond differently in acute health effects from healthy 
population after exposure to a subway environment, and therefore 
constitute (imply) a special risk group? 
 
4) Is PM10 mass concentration a sufficient indicator of general health risks 
from particles in different environments? 
 
5) To develop a method for labeling ultrafine carbon particles with indium-
111 that could be used in human pulmonary deposition and retention 
studies. 
 
6) To study lung deposition and retention of inhaled ultrafine particles using 
above mentioned  method and to 
a. estimate translocation of the particles 
b. analyze regional differences in the larger airways and in the 
alveolar region 
c. analyze interindividual differences related to sex, age and BMI. 
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4 METHODS 
This thesis is based on a series of human exposure studies. All participants gave 
their informed written consent to participate in each study. The studies were 
approved by the Regional Ethical Review Board at the Karolinska Institutet. 
Studies with ultrafine particles (papers III and IV) were also approved by local 
Radiation Protection at Karolinska University Hospital in Stockholm (Solna). 
The first two studies (papers I and II) with healthy volunteers and asthmatics, 
respectively, focused on exposure to “wear” particles (from wheel and brake wear 
etc.) occurring in the subway environment in Stockholm. These particles are 
generally larger than 1 micrometer in diameter and have a high content of metals, 
mainly iron. In the third study (paper III) we developed a method to produce an 
aerosol of ultrafine carbon particles labeled with radioactive indium (111In). This 
permitted the study of long-term deposition and translocation of inhaled 
nanosized carbon particles in healthy volunteers (paper IV). Additional 
information and more detailed description of each study are given in papers I–IV  
 
4.1 HUMAN EXPOSURE STUDIES IN STOCKHOLM SUBWAY 
ENVIRONMENT 
Study design 
A randomized, cross-over experimental design was used to study exposure to both a 
subway environment and an office environment (control). The volunteers served as 
their own controls. The design of the subway studies was similar to the previously 
mentioned road-tunnel exposure study [2] in order to facilitate a direct comparison with 
the road-tunnel study results. 
The Odenplan subway station in central Stockholm was selected for exposing 
subjects to a subway environment, as it is a representative subway station 
regarding particle exposure in Stockholm, with limited addition of motor 
combustion exposure. Subjects were exposed over a two-hour long period during 
the afternoon rush hour (4–6 P.M.), with the volunteers alternating 15 minutes of 
moderate exercise on a bicycle ergometer with 15 minutes of rest. The ergometer 
resistance was adjusted in order to achieve a standardized individual ventilation 
rate of 20 liters of air per minute and m2 of body surface area. Control exposures 
took place during corresponding hours in an office environment. The starting 
order of exposure (office vs subway environment) was randomized. The second 
exposure followed with an interval of at least three weeks. Bronchoscopies and 
blood sampling were performed 14 hours after each exposure. See Figure 2 below. 
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Figure 2. Study design: randomized crossover experimental design with exposure 
to a subway environment and an office environment (control).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Volunteers 
The participants in the two studies were all non- smokers: 20 healthy and 16 individuals 
diagnosed with asthma, respectively. All volunteers underwent routine physical 
examinations including a chest X-ray, an allergy screening for common inhaled 
allergens (Phadiatop test) and lung function tests. For basal characteristics of the study 
population, see Table 1. None of the healthy volunteers had any airway symptoms.  
For asthmatics an including criteria was to test positive in a bronchial 
hyperreactivity lung test (metacholine provocation). They were not allowed to use 
inhaled corticosteroids (anti-inflammatory medication) or any other anti-
inflammatory drugs for the last 3 months preceding their participation in the 
study. Short-acting non-corticosteroid treatment was permitted, however, when 
needed. 
 
Medical examination 
Two-hour long exposure in the subway/control environment at approximately  
4–6 PM included: Self-reported symptoms 
Lung function test (FEV1, PEF) 
Exposure measurements 
 
 
1) Lung function test (Spirometry, Exhaled NO) 
2) Peripheral blood 
3) Bronchoscopy  
14 hours 
 
Two-hour long exposure in the subway/control environment at approximately  
4–6 PM included 
Self-reported symptoms 
Lung function test (FEV1, PEF) 
Exposure measurements 
Minimum 3 weeks 
1) Lung function test (Spirometry, Exhaled NO) 
2) Peripheral blood 
3) Bronchoscopy  
 
14 hours 
 
FEV1, PEF at 8, 10 PM and app. 6–7 AM 
FEV1, PEF at 8, 10 PM and app 6-7 AM 
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The volunteers were not allowed use the subway on regular bases for at least two 
months before inclusion, or throughout the study period. They were told to 
perform ordinary daily activities, to avoid heavy physical activities during the 
days of measurements and to avoid staying in areas with heavy air pollution. 
During their participation in the study, the volunteers were without any 
symptoms of cold or other inflammatory symptoms for at least four weeks before 
each exposure.  
Table 1. Basal characteristics of the participants in the subway study.  
Characteristics Healthy 
volunteers 
Asthmatics 
Number of volunteers 20 16 
Women 7 11 
Mean age (range) years 27 (18–46) 26 (18–52) 
Positive for tested allergies  2 14 
Chest ray All normal All normal 
FEV1% pred ± SD 109 ±12 104 ±14 
Abbreviations: % pred = % predicted; FEV1 = forced expiratory volume in 1 sec. 
 
Environmental exposure measurements  
Extensive exposure measurements were performed during the subway exposure 
sessions: PM2.5 and PM10, particle number, nitrogen dioxide and carbon monoxide 
concentrations, humidity and temperature. The equipment used for particle 
measurements is presented in Table 2. The volunteers wore a passive sampler for 
measuring background nitrogen dioxide background exposure over 24 hours (including 
exposure). 
 
Particle mass levels (PM2.5 and PM10) were collected on filters using Harvard 
impactors. Sampled filters were also used for a further analysis of a range of 
metals. The number concentration of airborne UF particles was determined using 
a Scanning Mobility Particle Sizer (SMPS) system (for details see Papers I and II). 
During the control exposures, portable logging instruments were used to assess 
exposure. To enable comparison regarding particle exposure levels, these 
instruments were also used during exposure sessions in the subway environment. 
The two portable logging instruments used were a DataRAM, for measurements of 
mass of particles, and a P-Trak, a particle counter. For details see Table 2. 
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Table 2. Equipment used for particle measurements. 
Equipment Measurement of Additional information 
Mass concentration (ug/m3) 
Harvard 
impactors 
PM2.5 and PM10 particles Equipped with Teflon 
filters with a pore size of 2 
m 
DataRAM Particles between 0.1 and 10 
micrometer (µm) in diameter 
Calibrated by the 
manufacturer against a 
standard dust (Arizona 
road dust) 
Particle number concentration (particles/ml) 
Scanning 
Mobility 
Particle Sizer 
(SMPS) 
system 
Ultrafine particles between  
10–100 nanometers (nm) in 
diameter 
Consisting of Electrostatic 
Classifier model 3080 and 
Condensation Particle 
Counter (CPC) model 3010 
P-Trak Particles between 20–1000 nm in 
diameter 
 
 
Measurements of acute health effect 
Self-reported symptoms   
During the exposure sessions, self-reported symptoms of irritation from eyes, 
nose and lower airways, as well as experience of disturbing noise and smell, were 
recorded prior to and every 30 minutes throughout exposure. The intensity was 
graded from 0 to 10, where 0 corresponded to no symptoms and 10 to severe 
symptoms. 
Lung function tests  
Lung volumes (FEV1, FVC) were measured with a spirometer (Jaeger 
Masterscope). Measurements were performed immediately before 
bronchoscopies. In addition, a portable monitor (PIKO-1) was also used to 
measure forced expiratory volume (FEV1) and peak expiratory flow (PEF). 
Measurements with the PIKO-1 were collected immediately preceding the 
exposure session, after one hour of exposure, and immediately following the two-
hour session. Each volunteer was also instructed to repeat the measurements at 
around 8 PM, 10 PM, 6–7 AM, as well as at the clinic at 7:30-8 AM in the following 
morning, corresponding to 2, 4, 12–13 and 14 hours after exposure.  
Peripheral blood  
Peripheral blood was sampled in connection to bronchoscopy. Cell differential 
counts were performed, as well as an analysis of fibrinogen in plasma and 
plasminogen activator inhibitor-1 (PAI-1), both of which involve the coagulation 
system. Blood was also used for immunostaining and flow cytometric analysis, 
described further below. 
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Bronchoscopy, bronchoalveolar lavage and bronchial wash 
Bronchoalveolar lavage (BAL) was performed in the middle lobe with 5x50 ml 
sterile phosphate buffer saline by inserting a flexible fiberoptic bronchoscope 
under local anaesthesia. A BAL fluid (BALF) cell pellet was used for 
immunostaining and flow cytometric analysis. For details, see Papers I and II. 
The supernatant was analysed for inflammatory cytokines (IL-1β, IL-6, IL-8, IL-10, 
IL-12p70) and tumor necrosis factor-  (TNF- ). Bronchial washing was 
performed in a segmental bronchus in the upper lobe by instilling 2 x 10 ml sterile 
phosphate buffer saline.  
Immunostaining and flow cytometric analysis 
Lymphocytes from the BALF and peripheral blood samples were analyzed with a 
TBNK 6-color Multitest. TBNK reagent consists of a combination of antibodies for 
T cells, B cells and NK cells. We also used a set of monochlonal antibodies specific 
for markers of T-cell activity and of T-cell regulatory functions. For a list of the 
used markers, see General introduction (section Immune defence – response to air 
pollution).   
Statistical analysis 
Statistical analysis was carried out with SPSS versions 15.0 (paper I) and 17.0 
(papers I and II). Individual changes in different parameters for subway and 
control exposure were analyzed using Wilcoxon’s nonparametric rank sum tests. 
A paired t-test was performed for lung-function data and exposure measurements. 
Values of p<0.05 were regarded as significant. Descriptive statistical analysis was 
used in paper II-III, as well as a lineal least square fitting or linear regression 
model of the data.  
 
4.2 HUMAN EXPOSURE STUDIES WITH ULTRAFINE PARTICLES 
Generation of indium-111 labeled carbon particle aerosol 
To study lung deposition and retention of ultrafine particles, we needed to 
develop a method to label particles with a radioactive isotope, indium-111 (111In). 
The half-life of 111In is 2.83 days. The main emitted radiation is gamma (γ) 
radiation, but there is also some beta (β) radiation.  111In enables study of 
deposition and retention in humans for up to 30 days.  
A commercially available solution of 111In in hydrochloric acid was slowly heated 
using a silicon oil bath in a nitrogen atmosphere. This was done to remove the 
hydrochloric acid from the solution. After evaporation to dryness, distilled water 
was added, and the evaporation to dryness process was repeated (for a total of 
three times). Thereafter, the remaining 111In (free from hydrochloric acid) was 
dissolved in 99% ethanol. The solution was then placed in the graphite crucible of 
a commercially available, but slightly modified, Technegas generator and 
simmered for 15 minutes in pressurized air to cause indium oxidation (chemical 
reaction that involves transfer/loss of electrons).The crucible was then refilled 
with the indium solution and the simmering in air repeated. Thereafter, the 
indium-labeled ultrafine carbon particles were generated using a one-second 
crucible burning time at about 2500°C in order to keep the aerosol particle size as 
small as possible. To minimise particle agglomeration after generation, the aerosol 
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was directly diluted in a 70-liter flexible and conductive bag half-filled with clean 
air. Aerosol particle sizes and concentrations were measured with a Scanning 
Mobility Particle Sizer Spectrometer (SMPS) consisting of a Classifier 3080 and a 
Condensation Particle Counter (CPC) 3022A.  
Study design for human exposure studies  
After generation and dilution of particles in the flexible bag, the aerosol was 
administered to ten volunteers under spontaneous and normal tidal breathing. 
Each volunteer wore a nose clip and breathed through a mouthpiece. A calibrated 
pneumotachometer coupled to a pressure transducer was used to measure the 
inhaled and exhaled aerosol volume. A glass microfibre filter attached to the 
pneumotachometer was used to collect the exhaled aerosol. The total activity in 
this filter was measured using an ionization chamber.  
At each exposure event, the volunteers inhaled an air aerosol containing ultrafine 
particles labeled with the radioactive isotope indium-111. The radioactivity dose 
used was 4.8 mSv per person. A calibrated radiation protection monitor was used 
during aerosol inhalation to register the amount of radioactivity deposited in the 
lungs. Inhalation was terminated when the measured radiation reached a preset 
calibration value corresponding to approximately 1 MBq (the maximum permitted 
amount of radioactivity). After aerosol inhalation the subject rinsed the mouth 
with water to avoid ingestion of activity deposited in the oral cavity. Activity in 
lungs, blood, urine and in vitro was followed for 7 days (29 days in one case).  
The count median diameter (CMD) of the particle size distribution during the full 
exposure was estimated from the distributions of the aerosol samples taken 
immediately after dilution in the conductive bag and after administration to the 
subject. After administration, the remaining aerosol in the bag was filtered 
through a teflon filter using a vacuum pump. A sample of this filter was used for in-
vitro follow up of the activity leaching using the membrane diffusion technique. 
The study design for human exposure and follow-up shown in figure 3. 
Figure 3. Flow chart for human exposure studies with ultrafine carbon particles 
labeled with radioactive isotope indium-111. 
 
 
 
 
 
 
 
 
 
 
 
Preparation of indium-111 
 
Generation of ultrafine carbon particles labeled with indium-111 
 
Human exposure (n=10) 
 
Repeated measurements of activity in lungs (using a gamma camera), 
blood, urine, and in vitro for 7 days (29 days in one case) 
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Human exposure 
Ten non-smoking healthy volunteers (5 women) with a mean age of 29 years 
(range 20–54) participated in the study. All volunteers underwent a routine 
physical examination, including a lung function test performed with a spirometer. 
They were also screened for the presence of specific IgE antibodies against 
common inhaled allergens. Two of the ten volunteers had IgE antibodies to some 
radioallergosorbents (cladosporium, birch, cat, horse, etc).   
Stability: the bonding between indium-111 and ultrafine particles 
When tracing particles using a radiolabel, the degree of stability of the bond 
between particle and label must be assessed. An unstable bond will “leach” 
activity as free 111In, which will lead to difficulties in the interpretation of particle 
clearance. Dialysis was used to detect the levels of free (unbound) 111In.  
After each exposure, the remaining aerosol was filtered through a teflon 
membrane filter. The radioactivity of a piece of filter was measured in a sodium-
iodine well detector, and added into a 45-mm dialysis tube with pore size of 12–
14 kDa3. The tube was then sealed with belonging clips and covered by 100 ml of 
0.9% NaCl equilibration buffer, and the radioactivity was monitored for one week. 
“Leaching” is defined as the percent of radioactivity in the buffer compared to 
initial radioactivity in the teflon filter.   
Aerosol deposition, retention and clearance 
Pulmonary retention in lungs was monitored every 24 hours for a week using an 
image of the chest region (thorax, thyroid and upper abdomen) using a two-
headed gamma camera. Image acquisition was gradually incremented from 10 
minutes directly after the exposure to 25 minutes on the final day. For comparison 
a chest phantom was used filled with 1 MBq of 111In. Gamma camera image could 
then be used to correct the radioactivity in the lung versus the radioactivity on 
corresponding Teflon filter.  
Measurements in the chest region detected by gamma camera were not sufficient 
to evaluate whether the radioactivity was particle-bound or free in the body. In 
combination with the gamma pictures, blood and urine were also sampled every 
day for one week post exposure. These samples were dialyzed in a similar way as 
the filters. Dialysis of blood samples showed whether there was a translocation of 
labeled particles or free radioactivity from the lungs to the blood or not, and in 
urine samples whether there was a clearance of labeled particles from the body 
via urine. 
 
Extended lung retention follow-up for one volunteer 
For one female volunteer, an extended follow-up was performed using a whole-
body scanner with sodium iodide detectors at The Swedish Radiation Safety 
Authority. This method is more sensitive than using a gamma camera. The 
retention was normalized between these two modalities at day seven post 
exposure. One to four repeated measurements were performed at each occasion 
                                                 
3
 kDa = kilodalton. A unit for molecular weight or mass, where 1D is approximately 1.661×10−27 
kg. 
 20 
at days 7, 14, 22 and 29, both for the volunteer and reference material containing 
111In. The volunteer was 47-years old with a normal height (171 cm) and weight 
(72 kg) and with no history of pulmonary diseases or allergies. 
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5 RESULTS 
The main results from the four studies comprising this thesis are summarized 
below. Additional information and more detailed description of the study results 
are given in the paper I-IV.  
 
5.1 HUMAN EXPOSURE STUDIES IN SUBWAY ENVIRONMENT 
Healthy volunteers (paper I) were exposed for two hours to both a subway and a 
control environment in Stockholm. Acute health effects were monitored, such as 
lung function, inflammatory response in the lower airways (using bronchoscopy) 
and in peripheral blood, as well as fibrinogen as a marker of coagulation. No 
cellular (inflammatory) response was observed in the lower airways after 
exposure to the subway environment, although in peripheral blood we found a 
statistically significant increase of fibrinogen (coagulation marker) and increased 
levels of regulatory T-cells expressing CD4/CD25/FOXP3.  
We have previously shown that exposure to a road tunnel environment causes 
cellular inflammatory response in airways of healthy individuals. The subway and 
road tunnel environments have similar levels of mass PM10 and PM2.5, while the 
number concentrations of ultrafine particles, nitrogen monoxide and nitrogen 
dioxide are lower in the subway environment. Another difference between the 
two environments was that half of the PM10 fraction in the subway mainly 
consisted of iron, but also less than 1% of barium, manganese and copper. For 
details see Table 3.  
 
Table 3. Median value for environmental exposure measurements during 
exposure of healthy volunteers in the subway in comparison with levels in a 
previously investigated road-tunnel environment in the same city and during the 
same season. 
Type of exposure Subway 
environment 
Road tunnel 
environment 
Ultrafine particles  
(number of particles/ml) 
8 266 85 0004 
Approximate ultrafine particle surface 
area concentration (µm2/ml)  
845 732  
PM2.5 (µg/m3) 76  64  
PM10 (µg/m3) 237  176  
NO (µg/m3) 59  874  
NO2 (µg/m3) 24  230  
                                                 
4
 110 000 particles/ml (20-1000 nm) 
5
 The approximation may be compared to another more recent measurement of the particle surface area 
in Odenplan subway station, with a diffusion charging particle sensor (LQ1-DC (Matter Engineering 
AG). The mean particle surface area concentration for particles up to 10 µm in the subway was 70 (50-
100 µm2/cm3). (Midander et al, 2012; accepted for publication) [77] 
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A corresponding study with asthmatics (paper II) showed a statistically 
significant increased frequency of CD4 cells expressing T-cell activation marker 
CD25 in bronchoalveolar lavage fluid, furthermore, unlike in the study with 
healthy volunteers there was no significant increase of regulatory T-cells in blood. 
This means that inflammatory responses after exposure in subway environment 
differ between asthmatic and healthy humans. 
For other comparisons of acute health effects that were monitored, such as lung 
function, inflammatory response in the lower airways (using bronchoscopy) and 
in peripheral blood, as well as fibrinogen as a marker of coagulation, see table 4. 
When analysing lung function, as measured by a portable monitor (PIKO-1), only 
peak expiratory flow (PEF) was used, because of the potential measures, PEF was 
considered have more qualitative repeat- measurement accuracy in the absence of 
assisted supervision. 
 
Table 4. Dissimilar health effects in healthy and mild asthmatics after exposure to 
a subway environment (paper I-II), where  indicates an increased significant 
difference between subway and control exposure (p<0.05) and ns indicates a no 
significant difference between subway and control exposure.  
Parameter Healthy volunteers Asthmatics 
Lung function: VC, FVC, FEV1, PEF ns ns 
Cells in brochoalveolar lavage 
(BAL) and in in bronchial wash 
(BW):  
 recovery 
 viability 
 number of cells 
 cell concentration  
 % cell differentiation 
ns ns 
Blood cells: 
 cell concentration,  
 % cell differentiation 
ns ns 
Cytokines in BAL fluid: 
IL-1B, IL-6, IL-8, IL-10, IL-12p70, 
TNF-α 
ns ns 
Lymphocyte subsets in BAL fluid ns sign  CD4+CD25 
Lymphocyte subsets in blood sign : CD4+CD69 
CD4+HLA-DR 
CD8+CD69 
CD4+FoxP3 
CD4+CD25+FOXP3 
ns 
Symptom (irritation) sign : 
lower airways 
disturbing smell 
sign : 
eye, nose,  
disturbing smell 
PAI-1 in blood ns ns 
Fibrinogen in blood sign   ns 
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5.2 HUMAN EXPOSURE STUDY WITH ULTRAFINE PARTICLE AEROSOL 
Method development – labeling of ultrafine particles with indium-111 
We developed a method to produce stable carbon particles in nanosized-labeled 
indium-111 (111In) (paper III). To minimize the naturally occurring 
agglomeration of ultrafine particles, the particle aerosol was diluted and stored in 
a 70-liter conductive bag filled with clean air. The agglomeration rate of a typically 
sized carbon particle labeled with 111In is shown in figure 4 below.  The 
agglomeration followed a linear regression. 
 
 
 
 
 
 
Figure 4.  Aging effect on indium-111 labeled particles; size agglomeration after 
generation and during storage in a 70-liter bag filled with clean air.  
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Stability of particle label 
In order to use the developed method for human studies, it was important to 
generate carbon particles with a stable bond to indium-111. For tracing the 
degree of stability of the bond between particles and the isotope, we have used an 
in vitro dialysis technique. The generated particle aerosol was filtered through a 
teflon membrane filter and added to a dialysis tube. They were placed together in 
a sodium chloride buffer. The radioactivity detected in the buffer indicated 
“leaching” free (unbound) 111In. Figure 5 shows examples for the cumulative 111In 
radioactivity leaching from the carbon particles as a function of time after 
generation for three different initial particle sizes. This figure shows that more 
than 98% of the generated ultrafine particles were initially bound. Moreover, 
figure 5 shows that the radioactivity-leaching rate is particle-size dependent. For 
100 nm particles, the leaching was 0.01% per hour, for 70 nm it was 0.02% per 
hour and for 50 nm particles it was 0.18% per hour. Seven days after generation, 
the cumulative radioactivity leaching varied from 2 % to 5 % for 100 nm and 50 
nm initial particle sizes, respectively, this was satisfactory for use in human 
studies (paper III). Our aim in human studies was to generate 100 nm carbon 
particles. 
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Figure 5. Cumulative indium-111 radioactivity leaching rate from carbon 
particles for three different particle sizes. 
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Human exposure – study of pulmonary deposition, retention and clearance  
The inhaled ultrafine particles 
It took in average 1 min 50 s for the ten healthy volunteers (paper IV) to reach the 
goal of inhaling 1 MBq 111In labeled carbon aerosol. Particle size increased with 
time during exposure. Estimated mean value for the median of all exposures was 
84 nm (range 58-124), with a geometric standard deviation of 2.0 (1.6 – 2.2). The 
mean number concentration was 460 * 103 cm-3 (350-870).  
Stability of indium-111 labeled ultrafine particles used in human exposure studies 
In vitro dialysis we found that the bond between 111In and ultrafine carbon 
particles decreased linearly during the week. At the end of the week, the in vitro 
leaching of free unbound particles was 2.10%±1.60% at the group level. The 
cumulative in vivo leaching, calculated from measurements of free radioactivity in 
blood and urine, also gradually decreased. For urine it was 0.6%±0.4%, while in 
blood it was 1.5%±1.5%.  
Pulmonary deposition, retention and clearance of the inhaled particles 
Approximately 31.4% (±11%) of the inhaled original, particle-bound indium 
radioactivity was deposited in lungs of the volunteers. There was an even 
distribution over the lungs due to a low, central-airway impaction during 
administration. Retention of radioactivity in the pulmonary region was followed 
using gamma images of the chest region. The decreasing radioactivity in the 
pulmonary region corresponds to the amount of 111In labeled carbon particles that 
was cleared from the lungs. The elimination rate was faster in central regions (see 
figure 6) in comparison to peripheral, which is most likely due to the fact that 
mucocilliar transport is the dominant process in the central region.  
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Figure 6. Radioactivity retention, as measured with a gamma camera, in the 
central and peripheral lung regions as a function of time after administration of 
the 111In labeled ultrafine carbon particles.  
 
Seven days after exposure, lung retention as measured by gamma camera was 
91%±8.3% at the group level. After correction for free radioactivity leaching from 
urine and blood samples, respectively mucociliar clearance from the central 
airways, the cumulative lung-particle retention was approximated to 
96.4%±7.1%. The values at each time point represent a group-level average. The 
plot in figure 7 also presents the error bars corresponding to the fully corrected 
estimates of lung retention. Neither, sex, age nor BMI seemed to influence 
retention or clearance. 
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Figure 7. Pulmonary retention of inhaled 111In labeled carbon particles with and 
without corrections for radioradioactivity leaching (unbound 111In) and clearance 
from the central airways.  
 
Limited translocation to blood 
According to our estimation, the particle translocation from lungs, found in 
peripheral blood and urine, was rather small and did not change much during the 
week. After seven days it was 0.3%±0.2%. 
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Extended follow up for one volunteer 
One volunteer was monitored for 29 days (unlike the remainder were monitored 
for 7 days) after exposure. This female volunteer had a further clearance of 
approximately 10% from the lung region, see figure 8. 
 
 
 
 
 
Figure 8. Lung-retention measurements (uncorrected for leaching) of ultrafine 
carbon particles labeled with 111In with a sodium iodide scintillation detector for 
one person (◊), as well measurements of radioactivity for a reference material (_). 
The retention was normalized to previous measurements with a gamma camera 
(o) at day seven after exposure. 
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6 DISCUSSION 
6.1 ACUTE HEALTH EFFECTS CAUSED BY DIFFERENT PARTICULATE 
AIR POLLUTION 
Do acute health effects caused by particle exposure differ depending on size and 
composition? That was our primary objective when starting exposure 
measurements in an actual subway environment. Using an identical study 
protocol as in a previous study performed in a road tunnel environment enables 
us to compare the two environments regarding potential health effects. 
Analysis of the metal content in PM10 from the subway station showed a high 
metal content, mainly iron, which derives from the wear of wheels, rails and 
brakes (which is not the case in the road tunnel environment. An important 
difference between the two environments was that the number concentration of 
ultrafine particles was ten times higher in the road tunnel due to the motor 
exhausts, which mainly generate ultrafine particles. There were also high levels of 
NOx in the road tunnel, mainly from exhaust fumes, which is not present to any 
major extent in the subway. 
In vivo and in vitro studies show that ultrafine particles are more pro-
inflammatory than PM2.5 and PM10. In one in vivo study, carbon black as well as 
titanium dioxide was installed in rat lungs in both the size of 14-29 nm (ultrafine) 
respectively 250-260 nm (fine particles). The ultrafine particles showed to be 
significantly more pro-inflammatory, increasing neutrophils in the 
bronchoalveolar lavage fluid. [52] In another in vivo study in rats, the neutrophil 
influx in bronchoalveolar lavage fluid was also higher with ultrafine carbon black 
particles, rather than with particulate city air pollution (PM10) [51].   
 
Healthy individuals 
Our earlier in vivo study demonstrated that exposure to particles derived from 
road tunnel increased the amount of inflammatory cells (total cell number, 
lymphocytes and alveolar macrophages) in the BALF of healthy individuals. The 
participants also reported increased levels of irritative symptoms from eyes, 
upper (nose) and lower (lung) airways and an experience of disturbing odour. [2] 
 
Since the exposure levels regarding gravimetric parameters like PM2.5 and PM10 
were at equivalent levels when compared to the subway environment, it is 
reasonable to expect that the inflammatory effects observed in the road tunnel 
study also would be observed after exposure in the subway environment. 
However, no signs of cellular inflammatory response were observed in the lower 
airways after exposure to the subway environment, assessed by bronchoscopy, 
regardless of whether the cells were retrieved from peripheral (BAL fluid) or 
central (bronchial wash) airways. The exposure resulted in a significantly 
increased expression of markers for regulatory T cells as well as elevated levels of 
fibrinogen in peripheral blood in healthy volunteers. The participants reported 
increased levels of irritative symptoms lower airways and an experience of 
disturbing odour. 
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Studies on regulatory T cells is quite novel. Generally, T-regulatory cells are 
important in balancing or suppressing immune responses. At the time of our road 
tunnel study, we were unable to analyse for the marker for regulatory T cells. In 
that sense the results cannot really be compared. 
To our knowledge, there is only one previous study investigating acute health 
effects in humans caused by exposure in a subway environment. It showed that 
inflammatory response, measured as plasma concentrations of PAI-1, interleukin-
6 and fibrinogen, had a tendency to be higher for subway platform workers than 
for nonsmoking, healthy train drivers and subway ticket sellers [50]. In our study 
the plasma levels of fibrinogen also increased after the subway exposure, but not 
PAI-1. The increase of fibrinogen levels was however very modest and within 
normal range. No such effect was seen in the road tunnel study. However another 
study performed in in London, involving more than six thousand office workers, 
showed increased levels of urban PM10 correlated with increased levels of plasma 
fibrinogen[68]. 
The inflammatory response due to different type of particles, including subway air 
particulate matter (PM10) and diesel exhaust particles (DEP), has been studied in 
vivo in an animal study.  C57Bl/6 male mice were exposed to particles (5-
100 g/mouse) by intratracheal administration. Signs of inflammatory response 
were observed in bronchoalveolar lavage fluid 8 hours after 100 g/mouse 
exposure, with an increased number of neutrophils (due to subway particles and 
DEP) as well as pro-inflammatory cytokines TNF-  and MIP-26(due to subway 
air). [69] The discrepancies in inflammatory response with our subway results, 
with not as pronounced inflammatory response, may be explained by the 
difference in exposure methods. Intratracheal administration targets different 
lung compartments, versus normal inhalation of larger particulate matter. 
Health effects in asthmatics compared to healthy participants 
Inhaled particles in air pollution may exacerbate the already ongoing lung 
inflammation in asthmatics [31]. Our earlier in vivo study demonstrated that 
exposure to particles derived from road tunnel induced irritative symptoms from 
upper (nose) and lower (lung) airways, and decreased lung function (PEF) in 
asthmatic participants. In non-treated asthmatics there was an increase of pro-
inflammatory cytokines IL-12 and TNF-α, as well as of the anti-inflammatory IL-10 
in nasal lavage. [70] 
Even though asthmatics are known to be more sensitive to air pollution than are 
healthy persons with increased symptoms and emergency visits due to air 
pollution [71], this could not be clearly demonstrated in the present subway 
study. No effect on lung function (PEF) was demonstrated, but mild asthmatics 
exposed to a subway environment showed statistically significant increase of  
recruited CD4 cells expressing the T cell activation marker CD25 
(CD4pos/CD25pos) in lung in comparison to a control exposure. CD25pos is a 
general activation marker present on activated T cells in inflammatory reactions. 
This was not seen in healthy volunteers. In our study the CD4pos/CD25pos 
                                                 
6
 MIP-2= macrophage inflammatory protein 
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changes were seen in BAL, but not in blood, which suggest a local effect in the 
lungs. Our co-workers Lundström et al [72] have compared oxylipin levels in 
bronchoalveolar lavage (BAL) fluid from the same healthy and asthmatics, 
showing reduced anti-inflammatory response in asthmatics following exposure to 
the subway air. 
In our study asthmatics reported significantly increased irritation in the eyes and 
the nose during the exposure to the subway environment, as well as an increased 
experience of disturbing odour. Similar to asthmatics, self-reported experience of 
a disturbing odour was registered in healthy volunteers, but without 
corresponding significant changes in irritation in the eyes or nose. Instead, healthy 
subjects reported increased signs of irritation in the lower airways, which we 
found interesting. 
Regarding regulatory T cells that were induced in healthy but not asthmatic 
participants, there is at present limited knowledge regarding the role of regulatory 
T cells in asthma. Evidence suggests that asthma is characterized by a relative 
deficiency in regulatory T cells [73]. Such tendency was also seen in asthmatics in 
our study in comparison to the healthy participants.  
Differences in response due to different environments 
There is to our knowledge no other study that has investigated acute health effects 
in asthmatics caused by exposure in a subway environment. The acute health 
effects differ for asthmatics after exposure to road tunnel respectively subway 
environment. This may be due the presence of car exhaust in the road tunnel 
generating ten times higher levels of ultrafine particles and nitrogen oxides (NO 
and NO2), than was monitored in the subway environment. Association between 
ultrafine particles and asthmatic symptoms, but not PM2.5 and PM10, as well as an 
increased need of medication has been demonstrated in previous studies [32-34].  
Acute health effects response in asthmatics to environmental pollutants may differ 
depending on the composition and concentration of pollutants, as well as on 
asthma severity. For this study we chose a group of “mild asthmatics”, with no 
regular need of asthma medication, which could be one explanation to the weak 
responses observed in our study. In an in vivo study on asthmatics with a 2-hour 
exposure in a busy road in London found that road traffic exposure had a negative 
effect on the lung function of the asthmatics, as measured as FEV1 and FVC in 
comparison to exposure in a park. The effects were greater in moderate 
asthmatics compared to mild asthmatics. They furthermore found neutrophilic 
inflammation and decreased pH in sputum. Associations were strongest with 
ultrafine particles and with elemental carbon. [40] 
Acute health effects due to subway environment 
The results from our study show that healthy individuals exposed to the subway 
environment for two hours resulted in an up-regulation of T cells with a 
phenotype compatible with T cell regulatory functions, important for the 
regulation of immune tolerance, and a limited increase of fibrinogen levels in 
blood. It is still too early to conclude what an up-regulation may imposes 
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regarding evaluation of real health risk for the population exposed to the subway 
environment.  
One of the main result from our study shows that a two-hour exposure by 
asthmatic individuals leads to a different T cell response than for healthy 
volunteers in our previous study. There is a local activation of T cells in asthmatics 
in BAL fluid, while healthy volunteers demonstrated a systemic increase of 
regulatory T cells in blood that suppress the inflammatory response.  
Overall, acute health effects after exposure to our subway environment were few. 
Although no cellular response or increased levels of inflammatory cytokines were 
detected in either blood or BALF, the findings indicate a minor biological response 
due to the subway environment. Further studies are needed to evaluate these 
effects.  
Recently a new exposure study in the subway environment has been performed 
using repeated measurements to monitor possible earlier or later effects on the 
inflammatory responses. Since BAL is not a suitable method for repetitive 
measurements, repeated blood sampling was used. Blood sampling was also 
considered particularly suited for healthy volunteers, since the inflammatory 
effects were seen in their blood. The data are now being evaluated. 
 
6.2 PARTICLE EXPOURE LEVELS AS A HEALTH RISK INDICATATOR  
Monitored subway particle levels world-wide   
Our measurements in Stockholm subway show that the levels of particles are 
within levels reported world-wide in scientific literature (according to the table 5 
below). The subway system in Stockholm has only electrical driven subways and 
is almost free from motor exhaust coming from the ventilation system. This is not 
always the case in other subway systems. Even though particle levels may be 
similar world-wide and mainly contain iron, a risk assessment cannot be based 
solely on this exposure information since the chemical composition may still vary. 
Our study is however representative for the overall effects from rail wear 
particles. More complex measurements may be needed to cover other aspects of 
subway exposure.  
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Table 5. Particle levels in subway environments world-wide. 
City PM2.5 
(µg/m3) 
PM10 
(µg/m3) 
Ultrafine 
(particles/ml3) 
References 
Stockholm 63   [74] 
Stockholm 260 470  [1] 
Stockholm 77 242 8 280 [75] paper I 
Stockholm 71 232 8 960 [76] paper II 
Stockholm 60 160 12 000 
(20-1000 nm) 
[77] 
Stockholm  100-500  [78] 
Amsterdam 137 394 32 792 [3] 
Helsinki 47 & 60  31 000 [4] 
London 246   [5] 
London 270-480 1000-1500 14 000- 
29 0000 
[79] 
Mexico City  57   [80] 
New York 39  17 416 [6] 
Paris  68 resp 
361 
 [69] 
Prague  102  [81] 
Rome  35-479  [82] 
Seoul  126  [83] 
Seoul  129 359  [8] 
 
PM2.5 and PM10 – inadequate for assessing health risks 
Both the previous road tunnel environment and the current subway were found to 
have similar mass levels of particles at diameters <2.5 µm and <10 µm (PM2.5 and 
PM10), although the road tunnel had a higher number concentration of ultrafine 
particles as well as higher levels of nitrogen monoxide and dioxide. We found that 
different health impacts despite the similar PM2.5 and PM10 mass concentrations, 
and which implies that health-risk assessment cannot solely be based on this 
exposure information, since the particle characteristics can differ substantially by 
size and composition. More complex measurements of particles, including number 
concentration levels of ultrafine particles as the source of particles, are needed. 
 
6.3 PULMONARY DEPOSITION AND RETENTION IN HUMANS OF 
ULTRAFINE PARTICLES 
Indium-111 labeled ultrafine particles: high retention and minor 
translocation 
We successfully developed a method to generate indium-111 (111In) labeled 
ultrafine carbon particles for use in human studies. Human inhalation time was 
3.5 minutes to reach about 1MBq 111In-particle exposure. During this period, the 
subject was exposed to four times higher particle number concentrations than 
those measured in road tunnels [2]. One week post-administration, the average 
pulmonary radioctivity retention at group level was 91%, with a marginal particle 
translocation (0.3%) rom the lungs to peripheral blood. A 29-day follow-up was 
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performed for one volunteer, which showed that retention was reduced by 
another 10%. When corrected for activity leaching and central airway clearance 
by mucocilliar transport, the particle retention after one week was 96.4±7.1% at 
group level. The clearance rate was within the expected range with previously 
performed human studies.  
In our study the clearance was mainly from the central parts of the lungs. This was 
probably attributable to mucocilliar clearance from the larger airways. Normally, 
it is generally assumed that mucociliary transport is a process that terminates 
within a few days, which was also clearly seen in our studies. During the first 4 
days after exposure, there is a fast clearance rate, clearly representing mucocilliar 
transport, which then tapered off. Our previous human studies with 6, 8 
respectively 10 µm teflon particles also showed a faster clearance from large 
ciliated airways, while the more peripheral parts (ciliated bronchioles) had almost 
100% retention after 24 hours. In both regions the retained fraction was 
independent of particle size. [84] 
No inter-individual differences 
Neither the retention nor clearance was affected by age, sex or BMI. Our research 
team has previously performed several human exposure studies on deposition, 
retention and clearance of particles, mainly on larger teflon (4-16 µm) particles 
labeled with 111In. Ultrafine particles differ not only in chemical properties but 
also in surface properties, which makes it harder to compare the results. The 
surface area of a nano-sized atom or molecule has is much larger per given mass 
than for a micro-sized molecule. An increased area can also act as a carrier for 
more co-pollutants. Some general aspect can be concluded from those previous 
studies; for instance, retention within a group may vary more than that for each 
individual [60] and that long-term clearance (21 days) from the small airways 
decreases with age [85]. 
Marginal translocation 
There was marginal translocation of carbon particles from lungs to blood, which 
supports our earlier results on with 99Tcm-labeled ultrafine carbon particles with 
a size of 35 nm [86]. But as discussed by Wiebert et al, even small translocation 
from lungs into the circulation may have harmful health effects. In this context one 
needs to consider that low radioactivity levels are connected with possible 
uncertainties in the detection accuracy. 
There are limited human studies on translocation using ultrafine carbon particles. 
Due to safety aspects, are all short-term studies and show either no or limited 
translocation or major translocations of up to 1%. A 1% translocation lies at the 
interpretation threshold at which some authors referring to it as limited 
translocation [63, 64, 86-88] while another author may refer to it as a major 
translocation [65]. 
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Potential health problem due to the nano-size and solubility of particles 
Altogether, the results from our human study with high pulmonary retention of 
ultrafine carbon particles and with marginal translocation to blood, are consistent 
with previously performed short-term, follow-up studies by Wiebert et al [63, 
86]using 99mTc-labelled UF carbon particles.  
A potential health problem with the high pulmonary retention of ultrafine carbon 
particles is that they may have an inhibitory effect the phagocytic ability of 
alveolar macrophages, similar to particles derived from diesel exhaust. [59] The 
mentioned study was an in vitro study with human alveolar macrophages exposed 
to particles, which showed to have impaired attachment and ingestion process to 
silica particles and microorganisms. The authors concluded that this effect may 
result in more exacerbations of subgroups of chronic inflammation in their 
airways, as it may increase susceptibility to infections.  
In this context it is important to remark that in deposition studies the used carbon 
particles are non-soluble in the body liquids/tissues. However, their chemical 
property may differ from particles present in outdoor ambient air may comprise 
different chemical forms and hence be partly soluble in body fluids, and thereby 
result in different health effects. Furthermore, they can carry organic molecules of 
various types, possibly correlated to the onset of inflammatory processes in the 
body in relation to their accumulation in the body.  The solubility of particles 
being able to affect measurements of clearance and deposition was mentioned 
back in 1973 [89]. Furthermore, Philipson et al [90] showed that if insoluble 
particles reach the alveoli they will probably mainly be cleared by macrophagial 
phagocytosis and be transported to the ciliated airways where they are cleared 
out, a process that may take several years.  
Limitations – due to low radioactivity 
There are limitations of the technique because of the low radioactivity level used 
to study particles. In the (gamma camera) scintigraphic technique, the noise 
errors concerning particle distribution in the lungs increased with time. The low 
amount of inhaled radioactivity also represents a challenge regarding 
radioactivity-leaching measurements in blood and urine. The buffer to sample 
volume ratio in the dialysis process is crucial. In this work, we use a 100:1 buffer 
to sample the volume ratio. Larger buffer volumes are still desired, since the larger 
the buffer volume, the greater the diffusion gradient. However buffer volume is 
limited by the minimum detectable radioactivity concentration of the radiation 
detector used. Hence, a general approach for a better estimation of radioactivity 
leaching is to measure the radioactivity of the sample before and 24 hours 
postdialysis rather than buffer samples. In this way, the buffer can be renewed to 
ensure a good diffusion capacity throughout the entire period. 
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Low leakage or protein binding? 
Measurements of retention and clearance are highly dependent on the quality of 
the aerosol labeling, hence radioactivity-leakage studies are mandatory when 
using radiolabeling particles to study lung retention [91]. In our study, the 
bonding between particle and radionuclide was very stable. Seven days after 
exposure, the in vitro activity-leaching test showed a 3.2% free activity in the 
aerosol sample (at group level). This correlates well with the corresponding in 
vivo values of free activity measured in blood and urine (2.1% seven days after 
exposure). 
Leaching measurements with the dialysis-diffusion technique in blood cannot 
differentiate aerosol-bound radioactivity from free radioactivity bound to blood 
cells or proteins. Hence the dialysis method is still inconclusive for determining 
the presence of extrapulmonary aerosol particles. There was also a good 
correlation between the in vitro leaching test and with corresponding in vivo 
values of the free radioactivity measured in blood and urine, meaning that there 
probably was little other biological bonding to consider. Furthermore, this 
method, incorporates gamma camera imaging of the thorax and abdomen) may 
additionally offer a good indication of the nature of the bound radioactivity.   
Future research - effect on deposition and retention in injured lungs 
Little is known about how underlying inflammation or lung diseases may affect 
the deposition and retention of ultrafine carbon particles. What happens in the 
case of exposure with ultrafine particles? Do people with injured lungs have an 
increased translocation of particles into the blood circulation? Inconclusively, our 
previous studies with healthy and asthmatics found no difference in translocation 
of 99mTc labeled carbon particles after 24 hours (Wiebert, Sanchez-Crespo et al. 
2006). A study in COPD patients exposed to 99mTc-labeled carbon particles (larger 
than nanosize) showed a slightly increased deposition in comparison to a healthy 
subgroup. After 24 hours, there was a tendency toward increased retention in 
COPD patient (67%) compared to healthy subjects (64%) [87]. Furthermore, 
retention studies with larger particles (teflon labeled with indium-111) in patients 
with damaged lungs, e.g., patients with chronic bronchitis, showed higher 
pulmonary retention after 3 days [92], as well as after 21 days [93]. The method 
developed here, namely 111In-labeled nanosized particles, enables longer follow-
up studies of retention as well as translocation in individuals with underlying 
inflammation or lung diseases.  
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7 MAIN CONCLUSIONS 
1) Subway environment did not cause a classic inflammatory response (cellular 
response). 
 
2) The health effects after exposure to subway environment differed and were 
less pronounced from those observed after exposure to a road-tunnel 
environment. The different reactions indicate that other mechanisms might 
be relevant for health effects in humans. 
 
3) Our study shows that responses after exposure in subway environment differ 
between asthmatic and healthy humans. There was no convincing indication 
that asthmatics have a stronger reaction compared to healthy individuals. 
Asthmatics had changes locally in lower airways, while in healthy volunteers 
the signs indicated some systemic changes in blood. 
 
4) It is clear from our studies that even if different exposure environments have 
similar PM2.5 and PM10, mass concentrations, a health-risk assessment cannot 
solely be based on this exposure information, since the particle 
characteristics can differ substantially regarding size and composition. More 
complex measurements of particles, which include number concentration 
and composition of particles, are needed.  
 
5) The current study demonstrated that it is possible to generate and 
administer an  
indium-111 (¹¹¹In)-labeled ultrafine graphite (carbon) aerosol to humans. 
Compared to previously presented methods based on Technegas aerosol, the 
¹¹¹In labeled carbon particles also showed improved physicochemical 
properties. This allows extended follow-up assessments of particulate 
retention in healthy individuals, as well as in individuals with obstructive 
lung disease. 
 
6) Results from lung-deposition and retention studies indicate: 
a. There is limited translocation to the bloodstream in individuals with 
healthy lungs in the first week 
b. Clearance from the central lungs is probably attributable to 
mucocilliar clearance from the larger airways 
c. There is no association between pulmonary retention (clearance) and 
sex, age or BMI. 
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8 TACK – ACKNOWLEDGEMENTS 
Jag vill jag passa på att tacka ett antal personer som på var sitt sätt har varit med 
på den här disputationsresan. Det har totalt sett varit en givande, utvecklande och 
lärorik resa, som jag är tacksam över att ha fått varit med om. Det lär bli en lång 
tacklista det här… 
 
Mina ”två” huvudhandledare som under resans gång har skiftat i att vara 
huvudhandledare. Tack för er tilltro och ert förtroende till min kapacitet, och tack 
för all hjälp under resan. Ni har båda handlett mig helhjärtat, fast ni båda fysiskt 
sätt inte har jobbat kvar på Karolinska Institutet nu på slutet. Tack för alla era 
övergripande och detaljerade kommentarer, trots tidspress, vad gäller innehållet i 
kappan. Magnus Svartengren, det är du som har hållit i stafettpinnen nu på slutet 
och att du har tagit dig tid för att diskutera fakta med mig. Det har ju funkat bra 
det här, eller hur? Din veten-skapliga erfarenhet och kunskap är en ovärderlig 
källa. Partiklarnas värld är ditt område; där har jag fortfarande en hel del att lära.  
Britt-Marie Larsson, det har varit roligt att har fått jobba ihop med dig. Du har 
ofta varit mer än ”bara” handledare. Med dig som projektledare och det 
helhetsövergripande ansvaret, har jag på många sätt ”bara hängt på”. En lyxigt 
lång inkörnings-period med tid för eftertanke, analys och bearbetning av data. Din 
eviga optimism och tilltro på att ”det ordnar sig” smittar av sig. Och det har ju 
ordnat sig, eller hur?  
 
Alejandro Sánchez Crespo, min tredje handledare, vilken otrolig målinriktad 
förmåga du har som kör på tills saker blir färdiga. Inte undra på att du brukar 
springa maratonlopp. Det har varit stressigt emellanåt, men din inre plan verkar 
hålla. Jag har väl inte alltid varit införstådd i din plan, men har under vägen lärt 
mig att släppa på kontrollen.  Skönt att vårt samarbete har fungerat. Tack för all 
hjälp nu på slutet.   
 
Till alla medförfattare: Anders Eklund, Johan Grunewald, Anders Lundin, 
Charlotte Pousette, Magnus Sköld, Ingemar Rödin, Martin Andersson och Rolf Falk.  
Tack för ett bra samarbete och diskussion runt artiklarna, era alltid lika snabba 
svar och era bidrag till att få bra kvalité på artiklarna. 
 
Ett särskilt tack till Anders Lundin, Stina Gustavsson och Anneli Sandberg, 
som båda har varit oumbärliga i fältarbetet i doktrandprojekten. De hade inte 
varit möjliga utan personer som ni. Stina, tack för att du alltid har ställt upp, 
oavsett emellanåt konstiga arbetstider. Anders, jag värderar din nyfikenhet, 
kompetens och vilja att lösa alla praktiska ”klurigheter”. Du är en sann ingenjör. 
 
“Syrrorna” Heléne Blomqvist, Margitha Dahl, Gunnel de Forest på Lung-Allergi 
forskningen (KS), något av min andra ”bas” under doktorandtiden.  Tack för ert 
trevliga bemötande och er sanna omtanke. Ni har betytt mer för mig än ni nog 
anar. Tack även till nuvarande labbpersonal Benita Engvall och Benita Dahlberg 
på Lungforskningslabbet (KI) för all ert tålamod och tillmötesgående. 
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Tack till min doktorandmentor Madeleine Granvik, Institutionen för stad och 
land (SLU), för din vänskap, och ditt objektiva och konstruktiva sätt. Det har varit 
en befrielse att ha dig att bolla med under resans gång, särskilt då det har känts 
ensamt, förvirrat och frustrerande. 
 
Tack till PAHL-gänget med Per Gustavsson, Marie Lewné, Nils Plato och Magnus 
Alderling för visat förtroende och intressanta forskarmöten. Det är via ert projekt 
om partiklar, avgaser, hjärtinfarkt och lungmedicin (PAHL) som jag började på 
Arbets- och miljömedicin (SLL). Det förlängdes till forskningsassistentjobbet på 
Institutionen för folkhälsovetenskap (KI), Avdelningen för arbets- och 
miljömedicin, och slutligen till den nuvarande doktorandanställningen.  
 
Tack till alla nuvarande och före detta arbetskamrater på plan 3-4 på Norrbacka 
(tänk att det ska vara lättare att referera till en byggnad, än till en 
organisationsanknytning). Tack för er vänlighet, trivsamma möten, alla 
fikatillfällen, och alla ”vanliga dagar på jobbet”. Det var varit kul att gå till jobbet 
(!). Jag kommer sakna de återkommande konstutställningarna och 
fågelskådningarna ihop med er. Ert förebyggande folkhälsoarbete, relaterat till 
arbetsliv och miljön inom- och utomhus, är viktigt oavsett vilka vindar som än 
blåser. Ett särskilt tack till Lena Hillert för ditt stöd och ledarskap nu på slutet, 
samt Lotta Gustavsson, Tina Melander och Ann-Marie Windahl för att ni på ett 
beundransvärt sätt ser till att allt runt omkring ”flyter”.  
 
Tack ni alla nu disputerade doktorander (minst 21 under de här drygt sex åren) 
på Norrbacka, med mycket humor och glädje som kännetecken. Tack för era 
framträdanden och mottagningar på era respektive disputationsdagar: Andreas, 
Anna, Anne, Carolina, Daniel, Eva, Gun, Håkan, Ingegärd, Jenny, Kerstin, Marie, 
Mona, Ola, Ulrich, Per, Pernilla, Peter, Petter, Teresia och Wim. Lycka till Alma 
Sörberg och Katarina Aili (ni är ju snart halvvägs båda två), samt Julia 
Romanowska, Kerem Yazar, Olena Gruzieva och Johanna Kain i era respektive 
doktorandprojekt.  
 
Oj, oj… tack alla mina kära vänner. Vad vore ett liv utan er utanför jobbet? Några 
av er har varit särskilt intresserade av mitt jobbprojekt, men de flesta har jag bara 
fått vara ”Anna” med dvs umgåtts och fyllt på med energi med. Vill passa på att 
tacka er: Ann-Catrine, Anna L, Amanda, Johanna, Karin, Siobhán, Sr Margot och 
Titti. Luncherna med KemI-vännerna Anna N, Göran, Karin R, Åsa har också varit 
underbara avbrott att se fram emot. 
 
Tack till min förra chef Björne Olsson på Kemikalieinspektionen (KemI), för att 
du har varit så uppmuntrande kring min ”prova-på-forskningsidé”. Tack även till 
mina nuvarande KemI-chefer Agneta Westerberg och Camilla Zetterberg som har 
fortsatt att stötta mig. Skönt. Tack alla kollegor på KemI för ert intresse och 
nyfikenhet för mitt projekt. Vi ses 7 juni igen, då jag börjar jobba där jag slutade…  
 
Tack till min familj. Vad skönt att ni finns. Ett särskilt tack till mamma Alicja för all 
din omtanke, vardagsstöd och din orädda framåtanda där inget är omöjligt. Även 
pappa Zenons kritiska tänkande och ifrågasättande har varit en tillgång att bära 
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med sig. Kasia, min mentala coach. Tack för hjälpen med ”målbilder”, som har varit 
till nytta in i det sista. Gosia, tack för ditt stöd, din omtanke utan att du behöver 
säga så mycket, och nu senast för din hjälp med inbjudningskorten. Piotr, du vågar 
”hoppa” mot nya okända mål, vilket är stort. Mats & Katharina med döttrarna 
Linnea, Ellika och Astrid. Tack för att ni är så underbart välkomnande, 
accepterande och varma som familj, och för att ni har öppnat era hjärtan även för 
mig.  
 
Och allra mest, tack till min kära Bo and Sofia. Jag älskar er. Tack för att ni finns. 
Ni är min alldeles egna familj, glädje, trygghet och kärlekskälla. Må så få förbli och 
må vår varma familjekänsla bestå livet ut…  Det är till stor del er förtjänst att 
min djupa önskan om balans in livet, och om lugn och glädje i sinnet, oftast känns 
uppfylld nu förtiden. Det är stort för mig. Tack. 
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